Detalhe da pesquisa
1.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
2.
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.
Clin Infect Dis
; 78(3): 730-741, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874021
3.
The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study.
Antimicrob Agents Chemother
; 66(6): e0013622, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583344
4.
The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey.
New Microbiol
; 45(4): 260-268, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190370
5.
Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?
Antimicrob Agents Chemother
; 63(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910890
6.
Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review.
New Microbiol
; 41(4): 282-290, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252926
7.
Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209563
8.
On tuberculosis and COVID-19 co-infection.
Eur Respir J
; 56(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32586888
9.
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Eur Respir J
; 56(1)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457198
10.
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs.
J Antimicrob Chemother
; 70(9): 2572-5, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066583
11.
Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi.
Br J Clin Pharmacol
; 79(5): 801-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25377591
12.
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis.
J Antimicrob Chemother
; 69(1): 241-5, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23975735
13.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Lancet Respir Med
; 12(2): 117-128, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980911
14.
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
BMC Infect Dis
; 13: 563, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24289496
15.
Recent advances in the treatment of tuberculosis.
Clin Microbiol Infect
; 2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482332
16.
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs.
Br J Clin Pharmacol
; 83(5): 1146-1148, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097677
17.
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
PLOS Glob Public Health
; 2(12): e0001337, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962909
18.
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Trials
; 23(1): 484, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698158
19.
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.
BMJ Open
; 11(9): e047185, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489274
20.
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?
Int J Antimicrob Agents
; 57(3): 106297, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539932